High doses of aspirin best in colon cancer prevention

02/3/2004 | Reuters

New published research by U.S. scientists indicates the greatest benefits in colon cancer prevention occur when aspirin is taken in higher doses than those cited for heart disease prevention. But both the authors and a related editorial in the Annals of Internal Medicine cautioned there needs to be more evaluation of the risks of higher aspirin dosages, with the editorial warning that bleeding risk from high aspirin dosage may outweigh the anti-cancer benefits.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC